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Abstract Much of our knowledge concerning the genetics that
regulate cell death has come from the studies of cell death during
the development of the nematode Caenorhabditis elegans. Of the
14 genes identified as components of nematode cell death
pathways, two genes, ced-3 and ced-4, are required to promote
cell death and a third, ced-9, blocks cell death. Recent studies
show CED-4 to be an activator of CED-3 and CED-9 to be an
inhibitor of CED-4. Two published sequence alignments suggest
that CED-4 contains a death effector domain (DED), a protein
sequence motif present in other death signaling proteins like Fadd
and Flice; one study suggests a DED sequence similarity near the
N-terminus while the other found sequence similarity near the C-
terminus of CED-4. Using mutational analysis we have tested the
functional significance of the conserved residues found within the
putative DEDs of CED-4. Mutations in two conserved residues
within the putative N-terminal DED of CED-4 affected its
function, while mutations in the conserved residues within the
putative C-terminal DED had no effect on CED-4 function. Our
results do not support the presence of a DED in the C-terminus
of CED-4 and suggest a potential role for the N-terminus in
CED-4 function, possibly as a DED or as a CARD (caspase
recruitment domain). We also found that CED-9 associated with
all the CED-4 mutants and inhibited the activity of all the active-
CED-4 mutants.
z 1998 Federation of European Biochemical Societies.
Key words: Apoptosis; Ced-4; Death e¡ector domain;
FADD; FLICE; Caspase activation
1. Introduction
Apoptosis or programmed cell death is known to play an
important role in numerous biological processes [1^3]. Our
primary understanding of the molecular machinery that pro-
motes or prevents cell death has come from genetic analysis of
the nematode Caenorhabditis elegans [4]. In nematodes, 14
genes that participate in cell death have been identi¢ed [4,5].
Three of these 14 genes, ced-3, ced-4, and ced-9, control the
execution phase of cell death [6]. While CED-3 and CED-4
promote cell death, CED-9 opposes cell death. CED-3 is a
member of the caspase family of cysteine proteases that are
central components of the apoptotic pathway [7]. CED-4, a
homolog of the recently cloned mammalian pro-apoptotic fac-
tor Apaf-1, promotes the activation of CED-3, and thus leads
to the ultimate demise of the cell [8,9]. CED-9 is related to
mammalian Bcl-2, an anti-apoptotic factor. CED-9 opposes
cell death by associating with and blocking the activity of
CED-4 [10^16]. An additional role for CED-9 as a CED-3
inhibitor has also been proposed [17].
In mammals the Fas receptor is a conduit for transmission
of an external death-inducing signal known as FasL (Fas-li-
gand) [18^20]. Fas receptor, when occupied by FasL, recruits
caspase-8 via an adaptor protein Fadd. The recruited caspase-
8 is then activated leading to induction of apoptosis [18^20].
The interaction of caspase-8 and Fadd occurs through their
death e¡ector domains (DEDs), a protein motif present in the
N-terminus of both Fadd and caspase-8 [21,22]. Recently,
CED-4 was shown to interact with caspase-8, leading to spec-
ulation that CED-4 might function as an adaptor protein
analogous to Fadd [10]. Two sequence alignments, one sug-
gesting the presence of N-terminal DED in CED-4 and an-
other, a C-terminal DED, have been published [23,24]. Se-
quence alignment studies of CED-4 by Peter et al. [25],
based on other recently cloned DED containing proteins, sug-
gest that the previously published alignments of CED-4 with
DEDs might not be functionally signi¢cant. The functional
relevance of these alignments has not been tested yet.
In this study, we have replaced, by site-directed mutagene-
sis, seven residues conserved in the CED-4/DED alignments
of Bauer et al. [23] or Nagata [24] and assayed the e¡ect of
these mutations on the function of CED-4. We found that
mutations in two conserved residues in the potential N-termi-
nal DED a¡ected the function of CED-4, while none of the
four C-terminal DED mutants showed any signi¢cant reduc-
tion in their ability to promote apoptosis. All the functional
mutants of CED-4 were inhibited by CED-9 and were found
to associate with CED-9.
2. Materials and methods
2.1. Cells
The IPLB-Sf-21 cell line, originally derived from pupal ovaries of
the fall army worm Spodoptera frugiperda, was maintained at 27‡C in
TC-100 medium (Gibco BRL, Gaithersburg, MD) supplemented with
10% fetal bovine serum and 0.26% tryptose broth [26].
2.2. Plasmid constructs and site-directed mutagenesis
All plasmids used in this study were derived by replacing the chlor-
amphenicol acetyltransferase (CAT) gene in a previously described
vector, phsp70PLVI+CAT [27], thereby placing all genes under Dro-
sophila hsp70 promoter control. This promoter is active in Sf-21 cells
and can be induced further by heat shock, a procedure which, by
itself, does not induce apoptosis in Sf-21 cells [27]. Plasmids contain-
ing epitope-tagged versions of wild type (wt) ced-3, ced-4 and ced-9
were described previously and are as active as untagged versions in
apoptosis assays in Sf-21 cells [14]. While ced-3 contains an HA.11 tag
as a C-terminal fusion, ced-4 and ced-9 contain N-terminally fused
Flag and HA.11 tags, respectively [14]. All the ced-4 mutants were
derived using splicing by overlap extension (SOE) using appropriate
primers [28]. All the mutations were con¢rmed by sequencing. The
mutated versions of ced-4 are in the same vector (phsp70PLVI+CAT)
as wt Flag-ced-4 and contain a Flag tag as an N-terminal fusion. In
ced-4 mutants L17A, L71A, L444A, leucines at positions 17, 71, and
444, respectively, were replaced with alanine, and in F454A, phenyl-
alanine at position 454 was replaced with alanine. In E481A and
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E486A, an alanine replaced the glutamates at positions 481 and 486,
respectively. The previously described ced-4 mutant K165M contains
a lysine to methionine change at position 165 within the ATP/GTP-
binding motif [14].
2.3. Viability assay
Sf-21 cells (0.5U106 per 35 mm diameter tissue culture dish) were
transfected with indicated amounts of plasmid DNA using Lipofectin
(Gibco BRL). Cells were heat-shocked in a 42‡C water bath for 30
min beginning at 12^14 h post transfection. Viable cells excluding
trypan blue were counted at 10^12 h after heat shock administration
as previously described [27].
2.4. Multiple-sequence alignment
The regions in CED-4 predicted to contain a DED were aligned
with other cellular and viral proteins known to contain DEDs. The
sequence alignment was generated using the PileUp program of the
Genetics Computer Group program package (GCG, Madison, WI)
with a gap penalty of 3.0 and a gap extension penalty of 0.10. The
aligned sequences were then used to generate the ¢nal shaded align-
ment using the Boxshade program version 3.0 (created by Kay Hof-
mann, Bioinformatics group, ISREC, Switzerland).
The accession numbers for the sequences used are Q13158 for
Fadd, U58143 for Flice, U60519 for Mch4, AF009616 for Flame,
U60315 for molluscum contagiosum virus (MCV 159L/160L),
S55668 for equine herpesvirus-2 E8 (EHV-2), Z46385 for bovine her-
pesvirus E1.1 (BHV-4), Q01044 for herpesvirus saimiri gene 71(HVS),
U90534 for Kaposi’s sarcoma-associated herpesvirus orf K13 (HHV-
8) and P30429 for Ced-4.
2.5. Immunoprecipitation
At 4 h after heat shock, cells were collected and lysed in NP-40 lysis
bu¡er (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1.0% Nonidet P-40,
1 mM DTT) supplemented with protease inhibitor cocktail (Pharmin-
gen, San Diego, CA). Soluble proteins were precipitated using anti-
FLAG M2 a⁄nity resin (Eastman Kodak, New Haven, CT), washed
¢ve times in NP-40 lysis bu¡er, and resolved on a 10% acrylamide gel
by SDS-PAGE. The resolved proteins were electrophoretically trans-
ferred to Immobilon-P membrane (Millipore, Bedford, MA) and
probed with monoclonal HA.11 anti-rabbit IgG to detect coprecipi-
tating HA.11 epitope-tagged proteins. The expression of HA.11- or
Flag-tagged proteins in the detergent soluble fraction was determined
by Western blot analysis using either anti-HA.11 mouse monoclonal
IgG or anti-Flag mouse monoclonal IgG and an appropriate second-
ary antibody conjugated to horseradish peroxidase.
3. Results and discussion
3.1. N-terminal CED-4 mutants are defective in function
Although two amino acid sequence alignments have pre-
dicted the presence of two di¡erent DEDs in CED-4 based
on similarities to conserved death e¡ector domains of Fadd
and Flice (Fig. 1B,C) [23,24], the alignment of these two re-
gions with additional, more recently identi¢ed DED-contain-
ing proteins suggests that their homology to DEDs is weak
(Fig. 1A) [25]. To test the functional signi¢cance of these two
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Fig. 1. A: Multiple sequence alignment of the putative DEDs of CED-4 with other DED-containing proteins. B: Sequence alignment of CED-
4 with DEDs of Fadd and Flice according to Nagata [24]. C: Sequence alignment of CED-4 with DEDs of Fadd, Flice and Pea-15 as pub-
lished by Bauer et al. [23]. In B and C the asterisks (*) indicate residues that were mutated. The output of Boxshade is shown in panels A, B
and C. Boxshade uses a threshold function to identify identical and conserved residues within a position in the sequence alignment. The identi-
cal amino acid residues are enclosed in black boxes and similar amino acid residues are shown in shaded boxes. D: Schematic representation
showing the residues that were mutated in CED-4.
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previously published alignments, we created point mutants in
CED-4 at residues which are conserved within the putative
DED alignments (Fig. 1B^D), and tested these mutants for
function. Previously we have shown that CED-4 stimulates
and increases the levels of CED-3-mediated apoptosis in
Sf-21 insect cells [14]. We have used this assay to assess the
function of the mutant CED-4 constructs. In brief, Sf-21 cells
were transfected with plasmids expressing CED-3 or CED-3
and CED-4. Expression was induced by heat shocking and
viable cells were quantitated 10^12 h after heat shock. Cells
transfected with a plasmid expressing CAT served as the refer-
ence for 100% viability. The same plasmid was also used to
balance the plasmid levels in cotransfection experiments.
In the absence of CED-4, expression of CED-3 induced
apoptosis in about 21% of the cells (Fig. 2). Coexpression
of wt CED-4 with CED-3 increased the levels of apoptotic
cell death and about 45% of the cells were induced to undergo
apoptosis under this condition (Fig. 2 and [14]). As expected,
the previously reported null mutant of CED-4 K165M was
unable to increase the levels of apoptosis induced by CED-3
(Fig. 2, [14]). Similarly, two mutants in the putative N-termi-
nal DED, L17A and L71A, did not signi¢cantly increase the
levels of CED-3-mediated apoptosis (Fig. 2), indicating that
these two N-terminal residues of CED-4 are important for
the activity of CED-4. Expression of all the CED-4 mutants
was con¢rmed by Western blot analysis (see below). The
other mutants of CED-4, the N-terminal K46A, and the C-
terminal mutants L444A, F454A, E481A and E486A, were
not impaired in their ability to augment the levels of CED-
3-mediated apoptosis. The levels of apoptosis in cells ex-
pressing these mutants and CED-3 ranged from 44 to 49%
and did not signi¢cantly di¡er from the 44% cell death ob-
served in the presence of wt CED-4 and CED-3 (Fig. 2). None
of the four C-terminal mutants of CED-4 was a¡ected in
function. The alignment of the C-terminus of CED-4 with
the Flice and Fadd DEDs does not appear to be functionally
important.
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Fig. 2. Mutations in the amino-terminus of CED-4 a¡ect its func-
tion. Sf-21 cells were transfected with plasmids expressing either
CED-3 or CED-3 and CED-4 constructs as indicated. A plasmid ex-
pressing CAT was used to balance the amount of input DNA. At
12^14 h after transfection, expression was induced by heat shock,
and cell viability was determined at 10^12 h after heat shock. The
results indicate the viability of cells relative to cells transfected with
CAT-expressing plasmid alone (not shown) set at 100%.
Fig. 3. CED-9 inhibits active CED-4 mutants. Sf-21 cells were trans-
fected with plasmids expressing the various CED-4 mutants, CED-3
and CED-9 or CAT as indicated. The amount of input DNA was
kept constant by the addition of a plasmid expressing CAT. At 12^
14 h after transfection, the cells were heat-shocked to induce the ex-
pression from the transfected constructs. The number of viable try-
pan blue-excluding cells at 10^12 h after heat shock was used to
calculate percent apoptosis. The results shown are relative to the vi-
ability of cells transfected with CAT-expressing plasmid set at
100%.
Fig. 4. CED-4 mutants interact with CED-9. A: Sf-21 cells were
transfected with plasmids expressing Flag-tagged CED-4 wt or mu-
tants and HA.11 (Epi-)tagged CED-9 or CAT driven by Drosophila
hsp70 promoter, as indicated. Cells were heat-shocked 14 h after
transfection and cell lysates were prepared 4 h after heat shock in-
duction. Flag-tagged proteins were immunoprecipitated using anti-
Flag monoclonal antibody-coupled resin. Co-precipitating Epi-
tagged proteins were then detected by Western analysis using anti-
HA.11 monoclonal antibody. B: Expression of Epi-tagged proteins
in cell lysates prior to immunoprecipitation. Expression was detected
using anti-HA.11 monoclonal antibody. C: Expression of Flag-
tagged CED-4 proteins. The same membrane as in A was probed
with anti-Flag monoclonal antibody to detect expression of CED-4.
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3.2. CED-9 binds and blocks CED-4 mutants
We and others have shown that CED-9 binds and blocks
the activity of CED-4. Here we have tested the ability of
CED-9 to block the activity of CED-4 mutants [10^16]. Con-
sistent with our previous observation [14], CED-9 did not
signi¢cantly a¡ect CED-3-induced apoptosis when coex-
pressed with CED-3 (Fig. 3). Expression of CED-9 along
with CED-3 and CED-4 blocks the stimulatory activity of
CED-4, reducing the levels of apoptosis to 20% from 44%
seen in the absence of CED-9 (Fig. 3). When expressed with
the functional mutants of CED-4, CED-9 e¡ectively blocked
the activity of all the CED-4-mutants (Fig. 3).
We then tested if the ability of CED-9 to block CED-4
mutants coincided with the ability of the mutant CED-4 pro-
teins to interact with CED-9 (Fig. 4). We coexpressed Flag-
tagged CED-4 wt or mutants with HA.11 (Epi-)tagged CED-9
in Sf-21 cells. The Flag-tagged CED-4 proteins were immuno-
precipitated using anti-Flag antibody. Coprecipitating HA.11-
tagged (Epi) proteins were detected using an HA.11 antibody.
We found that, as with wt CED-4, all the mutants of CED-4
were able to interact with CED-9, which is consistent with the
ability of CED-9 to block the active CED-4 mutants (Fig. 4).
The speci¢city of this interaction was con¢rmed by the inabil-
ity of CED-4 to coprecipitate Epi-CAT (Fig. 4). The interac-
tion between the mutant CED-4 proteins and CED-9 shows
that the mutations in CED-4 did not alter the conformation
of CED-4 so as to signi¢cantly alter the ability of CED-4 to
interact with CED-9.
Although our functional analysis of CED-4 mutants does
not support the proposal of a DED in the C-terminus of
CED-4, the results do establish a role for the N-terminus of
CED-4 in its function. Two of the three mutations in this
region, the L17A and L71A mutations, eliminated the ability
of CED-4 to increase the levels of CED-3-mediated apoptosis.
The third mutation, K46A, had no e¡ect on CED-4 function
in this assay. However, this lysine residue is conserved only in
the original alignments of CED-4 which was limited to the
DEDs of Fadd, Flice and Pea-15 [23] and its relevance to
DED activity has not been established. The variability of
this region of DEDs and the non-conserved nature of this
lysine are revealed in more extensive alignments with addi-
tional, recently identi¢ed DEDs (Fig. 1A). In contrast, the
L17A and L71A mutations are well-conserved in both the
original and extended alignments. The fact that they inacti-
vate CED-4 indicates that they are functionally important but
does not necessarily con¢rm the presence of a DED in this
region. The region encompassing L17 and L71 has also been
found to show some sequence similarity to another motif, the
CARD (caspase recruitment domain), found in some caspases
and other apoptosis-related proteins. L17 and, to a lesser ex-
tent, L71 appear to be conserved within this CARD alignment
[29]. Our functional analysis does not distinguish if the region
functions as a DED or a CARD, or has yet some other
structural or biochemical function.
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